Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications
Authors:
- Francesca AddanteFAFrancesca Addante
- Antonio D’amatiAntonio D’amati
- Angela SantoroAngela Santoro
- Giuseppe AngelicoGiuseppe Angelico
- Frediano InzaniFIFrediano Inzani
- Damiano ArciuoloDADamiano Arciuolo
- Antonio TravaglinoATAntonio Travaglino
- Antonio RaffoneARAntonio Raffone
- Nicoletta D’alessandrisNDNicoletta D’alessandris
- Giulia ScaglioneGSGiulia Scaglione
- Michele ValenteMVMichele Valente
- Giordana TinnirelloGTGiordana Tinnirello
Top Cited Papers
Open Access
- 15 January 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 1056
Abstract
Among the four endometrial cancer (EC) TCGA molecular groups, the MSI/hypermutated group represents an important percentage of tumors (30%), including different histotypes, and generally confers an intermediate prognosis for affected women, also providing new immunotherapeutic strategies. Immunohistochemistry for MMR proteins (MLH1, MSH2, MSH6 and PMS2) has become the optimal diagnostic MSI surrogate worldwide. This review aims to provide state-of-the-art knowledge on MMR deficiency/MSI in EC and to clarify the pathological assessment, interpretation pitfalls and reporting of MMR status.Keywords
This publication has 99 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 yearsGynecologic Oncology, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomasThe Journal of Pathology, 2011
- ATR Mutation in Endometrioid Endometrial Cancer Is Associated With Poor Clinical OutcomesJournal of Clinical Oncology, 2009
- Clear Cell Carcinoma Compared to Serous Carcinoma in Early Ovarian CancerInternational Journal of Gynecological Cancer, 2009
- Molecular characterization of uterine clear cell carcinomaLaboratory Investigation, 2004
- Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinomaJournal of Medical Genetics, 2001
- MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomasOncogene, 1998
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983